The Comparative Effects of Civet-Containing and Musk-Containing WooHwangChungSimWon on the Central Nervous System

영묘향함유 우황청심원액과 사향함유 우황청심원액의 중추신경계에 대한 약리효과 비교시험

  • 최은욱 (서울대학교 천연물과학연구소) ;
  • 김기남 (서울대학교 천연물과학연구소) ;
  • 신상덕 (광동제약 주식회사) ;
  • 조명행 (서울대학교 수의과대학) ;
  • 마응천 (서울대학교 천연물과학연구소)
  • Published : 2000.10.01

Abstract

WooHwangChungSimWon is a traditional medicine for treatment of hypertension, arteriosclerosis, coma, and stroke in China, Korea, and Japan. In the new prescription of WooHwangChungSimWon, the civet is substituted for the musk, the major component of WooHwangChungSimwon, because of the prohibition law about the musk. We have made a comparative study of the effects on the central nervous system between the musk containing and civet containing WooHwangChungSimWon. In order to investigate the effects on the central nervous system, we have examined spontaneous motor activities, anti-convulsion activities induced by chemicals or electric shock, sleep induced by hexobarbital, and antistress effects. In the examination of anti-convulsion effects against the electric shock and injection of pentetrazol, only the civet containing WooHwangChungSimWon showed the anti-convulsion effects, i.e. the duration of convulsion by electric shock was decreased (control: 104.0 seconds, low dose of civet containing WooHwangChungSimWon: 60.7 seconds) and the duration of suppression against pentetrazol induced convulsion was increased (control: 392.3 seconds, low dose of civet containing WooHwangChungSimWon: 574.0 seconds, high dose of civet containing WooHwangChungSimWon: 561.4 seconds). In the other examinations, all kinds of WooHwangChungSimWon showed sedation, anti-convulsion activities, and induction of sleeping. These results suggest that there are no significant differences between the musk containing and civet containing WooHwangChungSimWon except the anti-convulsion effects against the convulsions induced by electric shock and pentetrazol.

Keywords

References

  1. 태평혜민화제국방 진사문
  2. 원본동의보감 허 준
  3. 방약합편 황도연
  4. 동의처방대전 염태환
  5. Jap. J. Pharmacol. v.16 Potentiation of β-adrenergic receptor to musk. Kimura. M;Waki. I
  6. Trends Pharm. Sci. v.7 Isoproterenol potentiation in an animal product-musk Kimura. M
  7. J. Pharm. Pharmacol. v.14 Anti-inflammatory effect of musk Mishra. R. K;Arora. R. B;Seth. S. D. S
  8. Ind. J. Physiol. Pharmac. v.17 Studies on the anti-inflammatory activity of Moschus Moschiferus(Musk) and its possible mode of action Taneja. V;Siddiqui. H. H;Arora. R. B
  9. Arch. Int. Pharmacodyn Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern Woodbury. L. A;Daveport. V. D
  10. J. Pharmacol. Exp. Ther. Comparative assays of antiepileptic drugs in mice and rats. Swinyard. E. A;Brow. W. C;Goodman. L. S
  11. J. Neurol. Sci. Suppl. v.2 A new model of focal brain ischemia based on the intracerebral injection of endothelin-1. Ital. Araki. L. F;Zoli. M;Kurosawa. M;Benfenati. F;Biagini. G;Zini. I;Hallstrom. A;Ungerstedt. U;Toffano. G;Fuxe. K
  12. Psychophamacologia. v.42 Behavioral supersensitivity to apomorphine following cerebral dopaminergic denevation by 6-hydroxydopamine Nahorski. S. R
  13. Biochem. Med. v.11 A rapid micromethod for the determination of ascorbic acid in plasma and tissues. Zannoni. V;Lynch. M;Goldstein. S;Sato. P
  14. 경희의학 v.19 우황청심원과 소합항원의 효능에 관한 연구 남상경;이경섭
  15. 대한한의학회지 v.11 우황청심원의 체형별 임상에 관한 연구 이원철;김영석;배형섭;구본흥
  16. 생약학회지 v.18 우황청심원의 순환기계에 미치는 영향 홍남두;김남재;김규섭
  17. J. Applied Pharmacol. v.5 Pharmacological actions of new woohwangchung-simwon liquid on cardiovascular system. Cho TS;Lee SM;Kim ND;Huh IH;Ann HS;Kwon KI;Park SK;Shim SH;Shin DH;Park KD